Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Weed (BUDZ) Cash & Equivalents (2017 - 2025)

Weed has reported Cash & Equivalents over the past 9 years, most recently at $33130.0 for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 79.21% year-over-year to $33130.0; the TTM value through Dec 2025 reached $33130.0, down 79.21%, while the annual FY2025 figure was $33130.0, 79.21% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $33130.0 at Weed, up from $400.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $821094.0 in Q2 2022 and troughed at $400.0 in Q3 2025.
  • A 5-year average of $159926.2 and a median of $36245.0 in 2021 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 30695.11% in 2022 and later tumbled 99.17% in 2024.
  • Year by year, Cash & Equivalents stood at $19654.0 in 2021, then soared by 1506.93% to $315826.0 in 2022, then fell by 8.05% to $290409.0 in 2023, then plummeted by 45.13% to $159355.0 in 2024, then crashed by 79.21% to $33130.0 in 2025.
  • Business Quant data shows Cash & Equivalents for BUDZ at $33130.0 in Q4 2025, $400.0 in Q3 2025, and $5350.0 in Q2 2025.